tegafur has been researched along with Hemangiosarcoma in 2 studies
Hemangiosarcoma: A rare malignant neoplasm characterized by rapidly proliferating, extensively infiltrating, anaplastic cells derived from blood vessels and lining irregular blood-filled or lumpy spaces. (Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kajihara, I | 1 |
| Kanemaru, H | 1 |
| Miyake, T | 1 |
| Aoi, J | 1 |
| Masuguchi, S | 1 |
| Fukushima, S | 1 |
| Jinnin, M | 1 |
| Ihn, H | 1 |
| Britsis, FA | 1 |
| Zakenfel'd, GK | 1 |
| Krampe, RA | 1 |
| Berzinia, VIu | 1 |
| Purkalne, TS | 1 |
2 other studies available for tegafur and Hemangiosarcoma
| Article | Year |
|---|---|
Combination chemotherapy with S-1 and docetaxel for cutaneous angiosarcoma resistant to paclitaxel.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Drug Resistance, | 2015 |
[Combined chemoimmunotherapy in stomach cancer and hematosarcoma].
Topics: Cyclophosphamide; Drug Therapy, Combination; Fluorouracil; Hemangiosarcoma; Humans; Immunotherapy; N | 1980 |